ACLX - Arcellx Inc

-

$undefined

N/A

(N/A)

Arcellx Inc NASDAQ:ACLX Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.

Location: 25 West Watkins Mill Road, Suite A, MD, 20878, US | Website: https://arcellx.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

3.691B

Cash

516.7M

Avg Qtr Burn

-5.003M

Short % of Float

14.29%

Insider Ownership

12.75%

Institutional Own.

95.41%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.